1. Azd-1222

   Case report 18 September 2021 Pages: 51 - 51

2. Azd-1222

   Case report 18 September 2021 Pages: 52 - 52

3. Basiliximab/methylprednisolone/mycophenolate-mofetil

   Case report 18 September 2021 Pages: 53 - 53

4. Bleomycin/cisplatin/etoposide

   Case report 18 September 2021 Pages: 54 - 54

5. Blinatumomab

   Case report 18 September 2021 Pages: 55 - 55

6. Bortezomib/daratumumab

   Case report 18 September 2021 Pages: 56 - 56

7. Bortezomib/dexamethasone

   Case report 18 September 2021 Pages: 57 - 57

8. Bortezomib/ibrutinib/rituximab

   Case report 18 September 2021 Pages: 58 - 58

9. Botulinum toxin A/gentamicin/influenza virus vaccine

   Case report 18 September 2021 Pages: 59 - 59

10. Brentuximab-vedotin

    Case report 18 September 2021 Pages: 60 - 60

11. Brolucizumab

    Case report 18 September 2021 Pages: 61 - 61

12. Buprenorphine/naloxone/morphine abuse

    Case report 18 September 2021 Pages: 62 - 62

13. Calcium-carbonate/omeprazole interaction

    Case report 18 September 2021 Pages: 63 - 63

14. Carbamazepine/fosphenytoin

    Case report 18 September 2021 Pages: 64 - 64

15. Carboplatin/dexamethasone/paclitaxel

    Case report 18 September 2021 Pages: 65 - 65

16. Carboplatin/etoposide

    Case report 18 September 2021 Pages: 66 - 66

17. Carvedilol

    Case report 18 September 2021 Pages: 67 - 67

18. Cefazolin

    Case report 18 September 2021 Pages: 68 - 68

19. Cefdinir/paracetamol

    Case report 18 September 2021 Pages: 69 - 69

20. Cefepime/tazobactam

    Case report 18 September 2021 Pages: 70 - 70

21. Ceftriaxone/cotrimoxazole

    Case report 18 September 2021 Pages: 71 - 71

22. Cenegermin

    Case report 18 September 2021 Pages: 72 - 72

23. Chlorphenamine/dextromethorphan overdose

    Case report 18 September 2021 Pages: 73 - 73

24. Cisplatin/docetaxel/fluorouracil

    Case report 18 September 2021 Pages: 74 - 74

25. Cisplatin/pembrolizumab/pemetrexed

    Case report 18 September 2021 Pages: 75 - 75

26. Citalopram/lithium/mianserin

    Case report 18 September 2021 Pages: 76 - 76

27. Cladribine/prednisone/thalidomide

    Case report 18 September 2021 Pages: 77 - 77

28. Clopidogrel

    Case report 18 September 2021 Pages: 78 - 78

29. Cobalamin/immune-globulin/methylprednisolone

    Case report 18 September 2021 Pages: 79 - 79

30. Colchicine

    Case report 18 September 2021 Pages: 80 - 80

31. Colchicine/prednisone

    Case report 18 September 2021 Pages: 81 - 81

32. Colistimethate sodium/tigecycline

    Case report 18 September 2021 Pages: 82 - 82

33. Cotrimoxazole

    Case report 18 September 2021 Pages: 83 - 83

34. COVID-19-Vaccine-Pfizer-BioNTech

    Case report 18 September 2021 Pages: 84 - 84

35. COVID-19-Vaccine-Pfizer-BioNTech/ciclosporin/mycophenolate sodium

    Case report 18 September 2021 Pages: 85 - 85

36. Crizotinib/gefitinib/osimertinib

    Case report 18 September 2021 Pages: 86 - 86

37. Cyanoacrylate

    Case report 18 September 2021 Pages: 87 - 87

38. Cyclophosphamide/dactinomycin/vincristine

    Case report 18 September 2021 Pages: 88 - 88

39. Cyclophosphamide/methylprednisolone/prednisolone

    Case report 18 September 2021 Pages: 89 - 89

40. Cytarabine/daunorubicin

    Case report 18 September 2021 Pages: 90 - 90

41. Cytarabine/daunorubicin/midostaurin

    Case report 18 September 2021 Pages: 91 - 91

42. Cytarabine/fludarabine/sorafenib

    Case report 18 September 2021 Pages: 92 - 92

43. Dapagliflozin

    Case report 18 September 2021 Pages: 93 - 93

44. Dapagliflozin/insulin-glargine

    Case report 18 September 2021 Pages: 94 - 94

45. Dapsone/sodium-nitroprusside

    Case report 18 September 2021 Pages: 95 - 95

46. Daratumumab/dexamethasone/rituximab

    Case report 18 September 2021 Pages: 96 - 96

47. Dasatinib/imatinib/nilotinib

    Case report 18 September 2021 Pages: 97 - 97

48. Dasatinib/imatinib/nilotinib

    Case report 18 September 2021 Pages: 98 - 98

49. Decitabine

    Case report 18 September 2021 Pages: 99 - 99

50. Dexamethasone

    Case report 18 September 2021 Pages: 100 - 100